Search This Blog

Sunday, April 16, 2023

AOC bashes Mayor Eric Adams’ overhaul of Medicare for 250K retired workers

 Rep. Alexandria Ocasio-Cortez took a swipe at both Mayor Eric Adams and the city’s union leaders — sharply criticizing a controversial plan to move 250,000 city retirees off traditional Medicare and into a privately managed version of the program.

AOC’s shot at City Hall over a concerning issue for seniors — a key voting constituency — could be a test of the waters for a Senate run against Democrat incumbent Kirsten Gillibrand, or even a challenge to Adams’ 2025 re-election bid, political consultants said.

The congresswoman has not ruled out a Senate run next year, and backed lefty challenger Maya Wiley’s failed run against Adams in the 2021 City Hall race.  

“It’s a bad decision. It is not good,” Ocasio-Cortez said about the change in health coverage for retirees during a virtual town hall Thursday.

“This is something I oppose. We are in this fight with you and we oppose this shift.”

Private health insurer Aetna will manage the Medicare Advantage program.

BILL DE BLASIO AND ALEXANDRIA OCASIO CORTEZ
Rep. Alexandria Ocasio-Cortez and former Mayor Bill de Blasio speak during a visit to a mobile vaccine bus on Castle Hill Avenue in the Bronx in 2021.
Pacific Press/LightRocket via Getty Images

The switch, initially proposed by former Mayor Bill de Blasio, enables the city to tap into an estimated $600 million in federal subsidies available to Medicare Advantage plans, lowering the city costs to provide health coverage to retired city government workers.

Adams advanced the program with changes — and it was overwhelmingly approved in a vote by the Municipal Labor Committee, the coalition of union leaders representing workers and retirees.

The switch will provide some new benefits, like routine hearing and vision exams, hearing aids, and mental health care via telemedicine. 

Mayor Eric Adams
Mayor Eric Adams and the city’s union leader’s plan would move 250,000 city retirees off traditional Medicare and into a privately managed version of the program.
NYC Mayor's Office

Aetna’s Medicare Advantage plan will have a lower annual deductible – $150 compared with $276 under SeniorCare, the city’s supplemental health plan for Medicare.

The Medicare Advantage deductible will also be waived during the 2023 calendar year.

But AOC suggested Medicare Advantage is a bait-and-switch.

Monthly bills on paper are lower but she warned retirees will get socked with higher bills if they’re hospitalized for a serious illness.

“A lot more of those costs are going to get moved onto you and moved onto seniors and retirees in a shift to Medicare Advantage,” she said, adding it’s “very concerning” the program will be run by a for-profit private insurer.

“This [Medicare Advantage] is a cash cow for them [private insurers]. It’s very profitable,” she asserted.

medicare protest
The plan will provide some new benefits, like routine hearing and vision exams, hearing aids, and mental health care via telemedicine. 
LightRocket via Getty Images

The congresswoman, who sources say has worked well behind the scenes with Adams despite some differences, didn’t criticize the mayor or any labor leader by name.

But AOC said retirees — who typically aren’t allowed to vote in elections to elect leaders of their unions — need to light a fire under union officials and Adams, who’s up for re-election in 2025.

“Do not give up,” she urged. “There needs to be pressure — and by the way, that needs to be electorally and also having those conversations with your union. Those are the folks who are at the negotiating table and there has to be accountability.”

Maya Wiley
AOC backed left challenger Maya Wiley’s run against Adams in the 2021 City Hall race. 
William Farrington

 The congresswoman, who represents portions of The Bronx and Queens, said Medicare Advantage has been rife with inflated bills and fraud, noting she was one of 70 House members who co-signed a letter to President Biden urging tighter controls to rein in program costs and prevent denials of services to seniors through “prior authorization.”

One veteran campaign vet said Ocasio-Cortez looks like she’s auditioning for another office.

“She’s got nothing to lose. Queens is the ground zero for the DSA [Democratic Socialists of America ] people. She would be a worthy challenger,” said political consultant Hank Sheinkopf.

“It’s a good way to test things. The Adams administration has every reason to be worried about the progressives, especially if crime doesn’t calm down, if the city still appears out of control. It wouldn’t be surprising that they are thinking about who they are going to run against him.” 

Alexandria Ocasio-Cortez
“This is something I oppose. We are in this fight with you and we oppose this shift,” AOC stated.
REUTERS/Evelyn Hockstein

On Sunday, the mayor defended the switch to Aetna-run Medicare Advantage as a win for the city and its retirees.

“The custom Medicare Advantage plan we will be offering to our city’s retirees starting later this year improves upon retirees’ current plans, including offering a lower deductible, a cap on out-of-pocket expenses, and new benefits, like transportation, fitness programs, and wellness incentives,” a statement from City Hall said..

“We also heard the concerns of retirees and worked to significantly limit the number of procedures subject to prior authorization under this plan. This plan is in the best interests of retirees and taxpayers, and we look forward to working with retirees, elected officials, and other stakeholders as the plan takes effect.”

Harry Nespoli, chairman of the Municipal Labor Committee and president of the Uniformed Sanitationmen’s Association, brushed off Ocasio-Cortez’s opposition to the Medicare switch.

Harry Nespoli, chairman of the Municipal Labor Committee and president of the Uniformed Sanitationmen’s Association, brushed off Ocasio-Cortez’s opposition to the Medicare switch.

“Tell her to give me a call at the union hall,” Nespoli said Sunday, defending the switch as prudent.

“It was time to do this. Governments have been moving into Medicare Advantage across the country.”

https://nypost.com/2023/04/16/aoc-bashes-mayor-eric-adams-overhaul-of-medicare-for-250k-retired-workers/

Vaxcyte to Discuss Results from Phase 2 Study of 24-Valent Pneumococcal Conjugate Vax

 Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it will hold a webcast and conference call tomorrow, April 17, 2023, at 7:30 a.m. Eastern Time to discuss results from the Phase 2 study of VAX-24, the Company’s lead, broad-spectrum 24-valent pneumococcal conjugate vaccine (PCV) candidate, in adults aged 65 and older and full six-month safety data from both adult Phase 2 studies.

To participate in the conference call, please dial (800)-267-6316 (domestic) or (203)-518-9783 (international) and refer to conference ID PCVX0417. A live webcast of the conference call will also be available on the investor relations page of the Vaxcyte corporate website at www.vaxcyte.com. After the live webcast, the event will remain archived on the Vaxcyte website for 30 days.

https://finance.yahoo.com/news/vaxcyte-host-webcast-conference-call-210000686.html

France's Ynsect to refocus bug business after capital increase

 French insect-based ingredients maker Ynsect will refocus its strategy on high-margin markets like pet food, shut a production plant and cut jobs after raising 160 million euros ($177 million) from investors, its chief executive said.

The company, which is in talks for additional funding, will use the money to finance expansion of its flagship vertical insect farm in Amiens in northern France, the world's largest, and for new projects, Antoine Hubert told Reuters in an interview.

Farmed bugs, such as mealworms, are ground down to produce proteins for aquaculture, livestock, pet food, fertilisers and human nutrition. They are considered more environmentally friendly proteins because they require less land and water than crops and emit fewer greenhouse gases.

But the technology is costly, making the meal far more expensive than its plant-based alternatives.

"In an environment where there is inflation on energy and raw materials but also on the cost of capital and debt, we cannot afford to invest loads of resources in markets which are the least remunerative (animal feed), while you have other markets where there is a lot of demand, good returns and higher margins," Hubert said, referring to pet food, human nutrition and fertilisers.

Ynsect will close its Dutch production plant, acquired through the takeover of Protifarm in 2021, which rears a different type of bug, while keeping research activities. This will lead to 35 job cuts.

In addition the company will cut 38 jobs in France, out of a total of about 360 people, Hubert said.

Ynsect, which announced agreements in December to build insect ingredient production sites in the United States and Mexico, has signed sales deals for 180 million euros over three years and is in talks for an additional 1 billion euros, of which more than half is for pet food, he also said.

In its latest round of fund raising in 2020 Ynsect brought in more than 315 million euros, of which about 175 million euros was capital and the rest in debt and subsidies.

Merck to acquire Prometheus Biosciences for $10.8B

 Merck & Co. is acquiring Prometheus Biosciences in a $10.8 billion deal.

All the shares of Prometheus Biosciences will be acquired by a subsidiary of Merck for $200 per share..

The deal gives Merck promising immune disease treatments.

The acquisition is subject to Prometheus Biosciences shareholder approval.

"The agreement with Prometheus will accelerate our growing presence in immunology where there remains substantial unmet patient need," said Robert M. Davis, Merck's chairman and chief executive officer. "This transaction adds diversity to our overall portfolio and is an important building block as we strengthen the sustainable innovation engine that will drive our growth well into the next decade." 

Prometheus had a market cap of $5.4 billion as of Friday’s market close. Its shares are up about 4% year-to-date.

Merck is looking to add new products to its pipeline as its top-selling drug cancer therapy Keytruda, is expected to lose patent protection this decade.

placeholder

Merck’s sales last year came to $59.3 billion, with Keytruda sales making up roughly $21 billion of it.

The San Diego-based Prometheus develops immune treatments and doesn’t have any approved products.

The company's pipeline drug in development treats immune diseases including ulcerative colitis and Crohn’s disease and recently reported separate positive study results in mid-stage testing.

Company sales totaled $6.8 million last year.

TickerSecurityLastChangeChange %
RXDXPROMETHEUS BIOSCIENCES INC.114.01+1.15+1.02%
MRKMERCK & CO. INC.115.31-0.27-0.23%

Merck recently made another deal, agreeing to acquire blood-cancer biotech Imago BioSciences for $1.35 billion.

https://www.foxbusiness.com/markets/merck-to-acquire-prometheus-biosciences-for-10-8b

800,000 nurses planning to leave the profession by 2027

 Nearly 100,000 registered nurses were estimated to have left the field during the COVID-19 pandemic and almost 800,000 intend to follow them out by 2027, according to a survey analysis released Thursday by the National Council of State Boards of Nursing (NCSBN).

Responses to the poll of more than 50,000 nurses suggest a net nursing workforce decline of 3.3% in the past two years, and a 2.7% decline in registered nurses (RNs) specifically, according to data published in the Journal of Nursing Regulation.

“The data is clear: the future of nursing and of the U.S. healthcare ecosystem is at an urgent crossroads,” Maryann Alexander, chief officer of nursing regulation at NCSBN, said in an accompanying release.

Of particular concern to NCSBN’s researchers were the recent and planned departures of nurses who were relatively new to the field. RNs with 10 or fewer years of experience accounted for almost 41% of the total drop-off of practicing RNs, they wrote. Another 15.2% said they planned to leave in the next five years, resulting in a net decline of 188,962 nurses.

On the other end of the spectrum, 44.8% of RNs with over 10 years of experience said they will likely leave in the next five years. This would subtract another 610,388 RNs from the workforce, according to the researcher's nationally weighted estimate.

Comparable declines also came among the survey’s support nurse respondents. Per the data, 4.2% (or an estimated 33,811) of licensed practical nurses/licensed vocational nurses left the workforce in the past two years—an issue compounded by “considerable and somewhat unprecedented disruptions” to prelicensure nursing education programs during the past few years.

The departures are likely tied to feelings of burnout and exhaustion reported by many of the responding nurses, researchers wrote.

Sixty-two percent of the sample said their workload had increased during the pandemic and others reported feeling emotionally drained (50.8%), fatigued (49.7%) or burned out (45.1%) at least a few times each week, according to the survey results. Free responses solicited from the nurses also frequently mentioned keywords related to COVID-19 stress (20.2%), unsafe staffing or work environments (23.2%), underappreciation (22.6%) and compensation (17.5%).

“The pandemic has stressed nurses to leave the workforce and has expedited an intent to leave in the near future, which will become a greater crisis and threaten patient populations if solutions are not enacted immediately,” NCSBN’s Alexander said. “There is an urgent opportunity today for health care systems, policymakers, regulators and academic leaders to coalesce and enact solutions that will spur positive systemic evolution to address these challenges and maximize patient protection in care into the future.”

NCSBN fielded its 2022 National Nursing Workforce Survey via direct mail outreach for a six-month period beginning April 11, 2022. About half of the respondents were RNs and many self-identified as female (92.5%), non-Hispanic (95%) and white (79.9%). The average age was 51 years and the median level of experience was 19 years.

NCSBN said the survey data subset used for the analysis was weighted to create a nationwide estimate of the departures and trends. The group also noted that its findings are in line with other warnings from industry analysts and warrant prompt attention from policymakers.

“Should some of the projections derived from this analysis and mirrored by government data and market research come to pass, the outlook for the U.S. healthcare system could be dire,” NCSBN’s researchers wrote. "Fortunately, projected intent to leave or retire is not static but rather a manipulable outcome depending on policymakers’ future decisions.”

https://www.fiercehealthcare.com/providers/about-800000-nurses-planning-leave-profession-2027-data-show-0

U.S. News Previews Top Med Schools After Major Players Ditch the Rankings

 In the wake of a number of top medical schools withdrawing from the annual U.S. News & World Report rankings

opens in a new tab or window, the outlet has released a preview of this year's highest performersopens in a new tab or window before the entire list is announced on April 18.

Rounding out the top three medical schools for research this year are Johns Hopkins University in Baltimore, the University of Pennsylvania's Perelman School of Medicine in Philadelphia, and Harvard University in Boston, respectively.

As of this year, Johns Hopkins was continuing to submit information to U.S. News for the rankings, while Harvard and the University of Pennsylvania had announced their plans to no longer do so.

A decampment of a number of medical schools from the rankings has closely followed that of a number of top law schools, and U.S. News simultaneously rolled out a preview of that list,opens in a new tab or window as well.

As for the outlet's decision to release a preview of this year's highest performers in a departure from its procedure in years prior, Eric Gertler, CEO of U.S. News, told MedPage Today in an email that "we are releasing these previews now to share the top 14 schools in the two categories that have gotten the most attention in the media, which represent approximately 10% of their respective student populations. We will release the complete graduate schools rankings on April 18, at which point we hope the attention will be focused on those schools that represent the remaining 90% of students seeking to make the best choice for their legal and/or medical education."

In an email to MedPage Today, a spokesperson for Johns Hopkins wrote that "Johns Hopkins Medicine is aware of the posting of a preview of the 2023-2024 U.S. News & World Report Graduate School rankings in which Johns Hopkins University School of Medicine is ranked as #1. In January 2023, we -- along with many peer institutions across the country -- made the decision to no longer participate in U.S. News & World Report's annual Best Medical Schools rankings."

"At the time of our decision, we had already submitted data for the rankings," the spokesperson noted, "however, we will not be doing so in the foreseeable future. This decision was driven by increasing concerns among medical schools about the publication's methodology and concerns that the ranking system does not provide a fair, comprehensive overview of each medical school, but instead employs metrics that are not clearly useful to students who seek relevant information to help them make choices about their medical education, and do not fully account for the many factors that distinguish one medical school from another."

U.S. News said that changes to the 2023-2024 "Best Medical Schools: Research" methodology include the following:

  • The addition of NIH Grant Awards as a measure of research quality
  • An increase in the weight of faculty-student ratios
  • A reduction in overall weight of reputation surveys
  • A reduction in MCAT and GPA scores

The outlet added that full methodology weights and measures will be available on April 18. It also addressed the departure of a number of medical schools from the annual rankings.

"Earlier this year, some medical schools chose not to provide their institution's statistical data to U.S. News," the outlet said. "In order to ensure that students had a fair basis for comparison, U.S. News used data from submitted statistical surveys in 2023 (or 2022 if 2023 was not available), and included publicly available metrics from the National Institutes of Health."

As Harvard led the pack in withdrawing from the rankingsopens in a new tab or window earlier this year, it credited its law school for helping to make that decision. George Q. Daley, MD, PhD, dean of the faculty of medicine, detailed that the decision was "more philosophical than methodological."

At the same time, a number of hospitals associated with some of the medical schools that have withdrawn pointed to inherent differences

opens in a new tab or window between the annual U.S. News "Best Hospitals" rankings, which are typically released in the summer, and the "Best Medical Schools" rankings.

Even so, U.S. News announced in February that it will make adjustments to the methodologiesopens in a new tab or window used to determine its "Best Hospitals" and "Best Children's Hospitals" rankings.

The rankings will assign more weight to clinical outcomes and other objective measures of quality, and less weight to the outlet's opinion survey of physicians, said Ben Harder, managing editor and chief of health analysis at U.S. News, in an online post at the time.

It remains to be seen what further changes may occur in the annual rankings, and whether more institutions will follow suit in declining to participate moving forward.

"We know how difficult it is to be a student searching for comparable information, and we will continue to incorporate data that medical schools reported directly to U.S. News over the past 2 years on the U.S. News' rankings and school profile pages, including indicators not used in the ordinal rankings and other critical information," the outlet said.

"More data on schools benefits everyone. U.S. News remains committed to collecting more data on the metrics that matter most to students in future iterations of our rankings," the outlet added.

The full preview list of this year's top medical schools is as follows:

1. Johns Hopkins University

2. University of Pennsylvania (Perelman)

3. Harvard University

4. University of California San Francisco (tie)

4. Washington University in St. Louis (tie)

6. Columbia University

7. Stanford University (tie)

7. Yale University (tie)

9. Duke University (tie)

9. University of Michigan-Ann Arbor (tie)

11. University of Pittsburgh

12. Northwestern University (Feinberg)

13. New York University (Grossman)

14. Cornell University (Weill) (tie)

14. Mayo Clinic School of Medicine (Alix) (tie)


https://www.medpagetoday.com/special-reports/features/103984